StreetInsider.com News Articles

Form 4 Addus HomeCare Corp For: May 21 Filed by: Lopez Esteban

Fri, 22 May 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260522/26542240.html

Form 4 Addus HomeCare Corp For: May 21 Filed by: Lopez Esteban

Fri, 22 May 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260522/26542240.html

Form 4 Addus HomeCare Corp For: May 19 Filed by: Lopez Esteban

Thu, 21 May 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260521/26535927.html

Form 4 Addus HomeCare Corp For: May 19 Filed by: Lopez Esteban

Thu, 21 May 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260521/26535927.html

Addus HomeCare (ADUS) Reiterated at Market Outperform by Citizens

Mon, 18 May 2026 07:18:50 -0400

Citizens analyst Constantine Davides reiterated a Market Outperform rating and $142.00 price target on Addus HomeCare (NASDAQ: ADUS).

The analyst commented, "ADUS trades at 8.5x our 2026 EBITDA estimate. Over the past 5 years, ADUS has traded between 8.5x and 17.5x NTM EBITDA, at an average of 13.4x. From 2021 to 2026, we estimate that EBITDA will grow at a CAGR of 15%, so we view the company's current valuation as a material discount to profit growth. We also believe that its current valuation does not contemplate: 1) upside from future M&A; 2) ADUS's ability to drive improved census dynamics across

Addus HomeCare (ADUS) PT Lowered to $92 at Barclays

Fri, 15 May 2026 04:42:23 -0400

Barclays analyst Andrew Mok lowered the price target on Addus HomeCare (NASDAQ: ADUS) to $92.00 (from $102.00) while maintaining a Underweight rating.

Addus HomeCare (ADUS) PT Lowered to $131 at TD Cowen

Fri, 08 May 2026 08:19:04 -0400

TD Cowen analyst Ryan Langston lowered the price target on Addus HomeCare (NASDAQ: ADUS) to $131.00 (from $140.00) while maintaining a Buy rating.

Addus HomeCare (ADUS) PT Lowered to $110 at BMO Capital

Wed, 06 May 2026 07:49:17 -0400

BMO Capital analyst Sean Dodge lowered the price target on Addus HomeCare (NASDAQ: ADUS) to $110.00 (from $120.00) while maintaining a Market Perform rating.

Addus HomeCare (ADUS) PT Lowered to $142 at Citizens on Missing Q1 Estimates

Wed, 06 May 2026 04:18:23 -0400

Citizens analyst Constantine Davides lowered the price target on Addus HomeCare (NASDAQ: ADUS) to $142.00 (from $150.00) while maintaining a Market Outperform rating.

The analyst commented, "On Monday after the market close, Addus HomeCare (ADUS) reported 1Q26 results. Consolidated revenue of $363.6M (+7.7% Y/Y) exceeded our $363.0M estimate but lagged consensus of $366.4M, with weather negatively impacting 1Q revenue by ~$1.5M. Personal care revenue of $281M eclipsed our $275M estimate, while hospice revenue of $66M came in below our $71M projection. EBITDA of $44.5M topped consensus ($44.2M) but came in just shy of our $44.9M estimate, with consolidated gross margin of

Addus HomeCare (ADUS) PT Lowered to $142 at Citizens on Missing Q1 Estimates

Wed, 06 May 2026 04:18:23 -0400

Citizens analyst Constantine Davides lowered the price target on Addus HomeCare (NASDAQ: ADUS) to $142.00 (from $150.00) while maintaining a Market Outperform rating.

Form 10-Q Addus HomeCare Corp For: Mar 31

Tue, 05 May 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260505/26435563.html

Form 10-Q Addus HomeCare Corp For: Mar 31

Tue, 05 May 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260505/26435563.html

Addus HomeCare (ADUS) PT Lowered to $130 at Jefferies

Tue, 05 May 2026 13:10:46 -0400

Jefferies analyst Brian Tanquilut lowered the price target on Addus HomeCare (NASDAQ: ADUS) to $130.00 (from $160.00) while maintaining a Buy rating.

Addus HomeCare to Participate in Upcoming Investor Conferences in May

Tue, 05 May 2026 11:00:00 -0400